EGF and non-small cell lung carcinoma: Herein, we first report that restricting [Ca2+]e on EGF-treated gefitinib-resistant NSCLC cells leads to the induction of [Ca2+]i oscillations, which is identical to the [Ca2+]i response in gefitinib-sensitive cells.